In Vitro NMR Spectroscopy in Neurological Diseases (SPECMET)
Evaluation of in Vitro NMR Spectroscopy to Identify Inborn Errors of Metabolism in Patients With Complex Neurological Diseases
Sponsor: Assistance Publique - Hôpitaux de Paris
Terminated
not enough enrollment
Other terminated trials from Assistance Publique - Hôpitaux de Paris
- Hepatocellular Carcinoma · Sep 2025
- Memory Consolidation · Phase NA · Aug 2025
- Knee Injuries · Apr 2025
- Metabolic Syndrome · Phase NA · Dec 2024
- Pulmonary Arterial Hypertension · Phase NA · Oct 2024
See all terminations from Assistance Publique - Hôpitaux de Paris
A observational or N/A phase clinical study on Neurological Diseases, this trial is terminated or withdrawn. The trial is conducted by Assistance Publique - Hôpitaux de Paris and has accumulated 9 data snapshots since 2006. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
Dec 2021 — Jul 2024 [monthly]
Terminated
-
Jan 2021 — Dec 2021 [monthly]
Terminated
-
Nov 2020 — Jan 2021 [monthly]
Terminated
▶ Show 4 earlier versions
-
May 2018 — Nov 2020 [monthly]
Terminated
-
Apr 2018 — May 2018 [monthly]
Terminated
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Terminated NA
-
Jan 2017 — Aug 2017 [monthly]
Terminated NA
First recorded
Jul 2006
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Assistance Publique - Hôpitaux de Paris
For direct contact, visit the study record on ClinicalTrials.gov .